Terazosin in the treatment of premature ejaculation: A short-term follow-up

International Urology and Nephrology

Volumn 37, Issue 4, 2005, Pages 773-777

  Başar, M Murad ^a,b   Yılmaz, Erdal ^a   Ferhat, Mehmet ^a   Başar, Halil ^a   Batislam, Ertan ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Alpha blockers; IIEF; IPSS; Lowerurinary tract symptoms; Prematureejaculation; Terazosine

Indexed keywords

PLACEBO; TERAZOSIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PREMATURE EJACULATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; URETHRA DISEASE;

EID: 31144467060     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-005-3616-4     Document Type: Article

References (23)

1. Master VA, Turek PJ. Ejaculatory physiology and dysfunction. Urol Clin North Am 2001; 28: 363-377. 10.1016/S0094-0143(05)70145-2 11402588 1:STN:280:DC%2BD3MzjsFKmsw%3D%3D
2. Masters WH, Johnson VE. Human Sexual Inadequacy. Boston: Little Brown & Co, 1970.
3. Rowland DL, Haensel SM, Blom JH, Slob AK. Penile sensitivity in men with prematre ejaculation and erectile dysfunction. J Sex Marital Ther 1993; 19: 189-197. 8246274 1:STN:280:ByuD28nhsF0%3D
4. Althof SE. Pharmacological treatment of rapid ejaculation. Psychiatr Clin North Am 1995; 18: 85-94. 7761310 1:STN:280:ByqB1c7ksVE%3D
5. Cavalini G, Alpha - 1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy. Eur Urol 1995; 28: 126-130.
6. Hsieh JT, Liu SP, Hsieh CH, Cheng JT. An in vivo evaluation of the therapeutic potential of sympatholytic agents on premature ejaculation. BJU Int 1999; 84: 503-506. 10.1046/j.1464-410x.1999.00173.x 10468770 1:CAS:528:DyaK1MXmsVahtrY%3D 000082682200020
7. Semans JH. Premature ejaculation: A new approach. South Med J 1956; 49: 533-538.
8. Berkovitch M, Keresteci A, Koren G. Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. J Urol 1995; 154: 1360-1361. 7658537 1:STN:280:ByqA1cjks1E%3D
9. Fein RL. Intracavernous medication for treatment of premature ejaculation. Urology 1990; 35: 301-303. 10.1016/0090-4295(90)80149-H 1690937 1:STN:280:By%2BB3cbgtVA%3D A1990CY80600004
10. Kaplan PM. The use of seratoninergic uptake inhibitors in the treatment of premature ejaculation. J Sex Marital Ther 1994; 20: 321-324. 7897680 1:STN:280:ByqB3crktlA%3D
11. Shilon M, Paz GF, Hommonai ZT. The use of phenoxybenzamine treatment in premature ejaculation. Fertil Steril 1984; 42: 659-661. 6541599 1:STN:280:BiqD38jotFY%3D
12. Waldinger MD. The neurobiological approach to premature ejaculation. J Urol 2002; 168: 2359-2367. 12441918
13. Beretta G, Chelo E, Fanciullacci F, Zanollo A. Effect of alpha-blocking agent (phenoxybenzamine) in the management of premature ejaculation. Acta Eur Fertil 1986; 17: 43-45. 3014791 1:STN:280:BimB28vjt10%3D
14. 2- Adrenoceptor antagonists: Effects o ejaculation, penile erection and pelvic thrusting behavior in dogs. Pharm Biochem Behav 2001; 70: 141-147. 1:CAS:528:DC%2BD3MXmt1KktL8%3D
15. Rosen RC. Lower urinary tract symptoms and sexual dysfunction: additional evidence of an association. BJU Int 2004; 93: 689-690. 10.1111/j.1464-410X.2003.04767.x 15049970 1:STN:280:DC%2BD2c7ls1OmsQ%3D%3D 000220463300001
16. Schou J, Holm NR, Meyhoff HH. Sexual function in patients with symptomatic benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 1996; 179: 119-122. 8908677 1:STN:280:ByiD28rht10%3D
17. Emberton M, Neal DE, Black N et al. The effect of prostatectomy on symptom severity and quality of life. Br J Urol 1996; 77: 233-247. 8800892 1:STN:280:BymB2crptlM%3D
18. Peters TJ. Relationship between LUTS and sexual function. Prostate Cancer Prostatic Dis 2001; 4: S2-S6. 10.1038/sj.pcan.4500520 12497052
19. Tubaro M, Polito M, Giambroni L et al. Sexual function in patients with LUTS suggestive of BPH. Eur Urol Suppl 2001; 40: 19-22.
20. Hofner K, Claes H, Reijke TMDe et al. Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol 1999; 36: 335-341. 10473995 1:CAS:528:DyaK1MXmsVOksbY%3D
21. O'Leary MP Quality of life and alpha-blocker therapy: An important consideration for both the patient and the physician Urology Suppl 2002; 59: 7-11.
22. Schulman C. Impact of treatment of BPH on sexuality. Prostate Cancer Prostatic Dis 2001; 4: S12-S16. 10.1038/sj.pcan.4500541 12497054
23. Debruyne FM, Van der Poel HG. Clinical experience in Europe with uroselective alpha 1-antagonists. Eur Urol Suppl 1999; 36: 54-58 1:CAS:528:DyaK1MXkvFCku78%3D